Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.25%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +35.58%
#5 Humanity Humanity +26.67%
#6 Codatta Codatta +18.76%
#7 Walrus Walrus +18.15%
#8 Enso Enso +18.11%
#9 The Black Bull The Black Bull +14.64%
#10 Collector Crypt Collector Crypt +14.30%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Lysogene S.A. Lysogene S.A.

Lysogene S.A.

LYS
Rank in Stocks #36618
Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy,... Lysogene S.A. is a biopharmaceutical firm specializing in gene therapy, dedicated to discovering and advancing treatments for children affected by severe neurodegenerative lysosomal storage disorders. Its development pipeline includes LYS-SAF302, which is currently undergoing Phase II/III clinical trials for mucopolysaccharidosis type IIIA (MPS IIIA). Another promising candidate, LYS-GM101, is in Phase I/II development, targeting GM1 gangliosidosis. The company has also forged a research alliance with the Weizmann Institute of Science to pioneer novel adeno-associated virus (AAV) gene therapy approaches for conditions such as neuronopathic Gaucher disease, Parkinson's disease, and other related illnesses. Lysogene S.A. was established in 2009 and is headquartered in Neuilly-sur-Seine, France.
Share Price
$0.30221445
Last synced: 2023-05-22
Market Cap
$2.49M
Change (1 day)
-0.10%
Change (1 year)
0.00%
Country
FR
Trade Lysogene S.A. (LYS)

Category

Healthcare
P/S ratio for Lysogene S.A. (LYS)
P/S ratio as of 2026 TTM: 0
According to Lysogene S.A. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Lysogene S.A. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE